Citadel Advisors’s Allergan Inc AGN Stock Holding History

Citadel Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-74,100	Closed	-$15.8M	–	9376
2014 Q4	$15.8M	Sell	74,100 -47,300	-39%	-$9.41M	0.02%	1104
2014 Q3	$21.6M	Sell	121,400 -30,800	-20%	-$5.12M	0.02%	861
2014 Q2	$25.8M	Buy	152,200 +32,000	+27%	+$4.98M	0.03%	677
2014 Q1	$14.9M	Buy	120,200 +13,800	+13%	+$1.68M	0.02%	1017
2013 Q4	$11.8M	Buy	106,400 +20,200	+23%	+$1.93M	0.02%	1105
2013 Q3	$7.8M	Buy	86,200 +8,800	+11%	+$790K	0.01%	1262
2013 Q2	$6.52M	Buy	+77,400	New	+$8.03M	0.01%	1338

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Citadel Advisors's AGN Position: Q1 2015 in Review

Citadel Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 708,361 shares — an estimated $151M sold.

Citadel Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $259M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Citadel Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Citadel Advisors sold 708,361 Allergan Inc shares in Q1 2015, an estimated $151M.
Citadel Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Citadel Advisors's Allergan Inc position peaked at $259M in Q4 2013.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Citadel Advisors's 13F filing for Q1 2015, filed 15 May 2015.